Biotechnology
Browse our all latest published reports on Biotechnology
Recombinant Proteins Market Size, Trends, Analysis and Forecast till 2034
Recombinant Proteins Market Size, Share, By Product (Hormone, Growth Factors, Enzymes, Antibodies, and Others), By Application (Research, therapeutics, biotechnology, disease diagnostic, and others) and By Region - Trends, Analysis and Forecast till 2034
U.S Cell and Gene Therapy CDMO Market Size, Trends, Analysis and Forecast till 2034
U.S Cell and Gene Therapy CDMO Market Size, Share By Service Area (Cell Therapy, Plasmid DNA, Viral Vector, and Others), By Indication (Cancer, Cardiovascular Disease, Infectious Disease, Genetic Disorders, Neurological Disorders), By Phase (Phase 1, Phase 2, Phase 3, Phase 4) - Trends, Analysis and Forecast till 2034
North America Cell and Gene Therapy CDMO Market Size, Trends, Analysis and Forecast till 2034
North America Cell and Gene Therapy CDMO Market Size, Share By Service Area (Cell Therapy, Plasmid DNA, Viral Vector, and Others), By Indication (Cancer, Cardiovascular Disease, Infectious Disease, Genetic Disorders, Neurological Disorders), By Phase (Phase 1, Phase 2, Phase 3, Phase 4) and By Country - Trends, Analysis, and Forecast till 2034
Europe Cell and Gene Therapy CDMO Market Size, Trends, Analysis and Forecast till 2034
Europe Cell and Gene Therapy CDMO Market Size, Share By Service Area (Cell Therapy, Plasmid DNA, Viral Vector, and Others), By Indication (Cancer, Cardiovascular Disease, Infectious Disease, Genetic Disorders, Neurological Disorders), By Phase (Phase 1, Phase 2, Phase 3, Phase 4) and By Country - Trends, Analysis and Forecast till 2034
Asia Pacific Cell and Gene Therapy CDMO Market Size, Trends, Analysis and Forecast till 2034
Asia Pacific Cell and Gene Therapy CDMO Market Size, Share By Service Area (Cell Therapy, Plasmid DNA, Viral Vector, and Others), By Indication (Cancer, Cardiovascular Disease, Infectious Disease, Genetic Disorders, Neurological Disorders), By Phase (Phase 1, Phase 2, Phase 3, Phase 4) and By Country - Trends, Analysis and Forecast till 2034
U.S. CAR-T Cell Therapy Market Size, Trends, Analysis and Forecast till 2034
U.S. CAR-T Cell Therapy Market Size, Share By Drug Type (Ciloleucel, Axicabtagene, Brexucabtagene Autoleucel, Tisagenlecleucel, and Others), By Indication (Acute Lymphocyctic Leukemia, Lymphoma, Non-Hodgkin Leukemia and Others), By End-Users (Hospitals, Cancer Research Centers, and Others) - Trends, Analysis and Forecast till 2034
North America CAR-T Cell Therapy Market Size, Trends, Analysis and Forecast till 2034
North America CAR-T Cell Therapy Market Size, Share, By Drug Type (Ciloleucel, Axicabtagene, Brexucabtagene Autoleucel, Tisagenlecleucel, and Others), By Indication (Acute Lymphocyctic Leukemia, Lymphoma, Non-Hodgkin Leukemia and Others), By End-Users (Hospitals, Cancer Research Centers, and Others) and By Country - Trends, Analysis and Forecast till 2034
Europe CAR-T Cell Therapy Market Size, Trends, Analysis and Forecast till 2034
Europe CAR-T Cell Therapy Market Size, Share, By Drug Type (Ciloleucel, Axicabtagene, Brexucabtagene Autoleucel, Tisagenlecleucel, and Others), By Indication (Acute Lymphocyctic Leukemia, Lymphoma, Non-Hodgkin Leukemia and Others), By End-Users (Hospitals, Cancer Research Centers, and Others) and By Country - Trends, Analysis and Forecast till 2034
Asia Pacific CAR-T Cell Therapy Market Size, Trends, Analysis and Forecast till 2034
Asia Pacific CAR-T Cell Therapy Market Size, Share, By Drug Type (Ciloleucel, Axicabtagene, Brexucabtagene Autoleucel, Tisagenlecleucel, and Others), By Indication (Acute Lymphocyctic Leukemia, Lymphoma, Non-Hodgkin Leukemia and Others), By End-Users (Hospitals, Cancer Research Centers, and Others) and By Country - Trends, Analysis and Forecast till 2034
Exosome Diagnostics and Therapeutics Market Size, Trends, Analysis and Forecast till 2034
Exosome Diagnostics and Therapeutics Market Size, Share, By Product Type (Reagents & Kits, Instruments, and Software), By Source (Blood & Blood Plasma, Stem Cells, and Urine), By Application (Diagnostics and Therapeutics), By End-User (Hospitals & Clinics, Research Institutions, and Pharmaceutical companies), and Region (North America, Europe, Asia Pacific, Middle East and Africa, and South America) - Trends, Analysis and Forecast till 2034